PL1856153T3 - Przeciwciała monoklonalne YKL-40 - Google Patents

Przeciwciała monoklonalne YKL-40

Info

Publication number
PL1856153T3
PL1856153T3 PL06706064T PL06706064T PL1856153T3 PL 1856153 T3 PL1856153 T3 PL 1856153T3 PL 06706064 T PL06706064 T PL 06706064T PL 06706064 T PL06706064 T PL 06706064T PL 1856153 T3 PL1856153 T3 PL 1856153T3
Authority
PL
Poland
Prior art keywords
ykl
antibodies
pharmaceutical compositions
relates
growth
Prior art date
Application number
PL06706064T
Other languages
English (en)
Inventor
Richard Bonnichsen
Paul A Price
Original Assignee
Bio Y As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36385676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1856153(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Y As filed Critical Bio Y As
Publication of PL1856153T3 publication Critical patent/PL1856153T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06706064T 2005-02-28 2006-02-16 Przeciwciała monoklonalne YKL-40 PL1856153T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200500300 2005-02-28
EP06706064A EP1856153B1 (en) 2005-02-28 2006-02-16 Ykl-40 monoclonal antibodies
PCT/DK2006/000093 WO2006089549A1 (en) 2005-02-28 2006-02-16 Ykl-40 monoclonal antibodies

Publications (1)

Publication Number Publication Date
PL1856153T3 true PL1856153T3 (pl) 2011-06-30

Family

ID=36385676

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06706064T PL1856153T3 (pl) 2005-02-28 2006-02-16 Przeciwciała monoklonalne YKL-40

Country Status (10)

Country Link
US (2) US8053563B2 (pl)
EP (1) EP1856153B1 (pl)
JP (1) JP2008531608A (pl)
AT (1) ATE493439T1 (pl)
AU (1) AU2006218237B2 (pl)
CA (1) CA2599439A1 (pl)
DE (1) DE602006019205D1 (pl)
ES (1) ES2358917T3 (pl)
PL (1) PL1856153T3 (pl)
WO (1) WO2006089549A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229770B1 (en) 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
AU2002319680B2 (en) 2001-07-24 2008-04-10 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1856153B1 (en) * 2005-02-28 2010-12-29 Bio-Y A/S Ykl-40 monoclonal antibodies
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
US8697384B2 (en) 2008-01-23 2014-04-15 Herlev Hospital YKL-40 as a general marker for non-specific disease
CN101587125B (zh) * 2008-05-21 2013-07-24 林标扬 高表达癌症标记物和低表达组织器官标记物组合试剂盒
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
CN104335045B (zh) * 2012-02-27 2017-02-22 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN105092855B (zh) * 2014-05-23 2017-10-03 杭州普望生物技术有限公司 一种用于肝纤维化和肝硬化检测的试剂盒
US10473671B2 (en) 2014-12-18 2019-11-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3565596A4 (en) 2017-01-05 2020-12-16 Brown University PROCESSES AND COMPOSITIONS RELATING TO ANTI-CHI3LI ANTIBODY REAGENTS
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer
WO2019060675A1 (en) * 2017-09-21 2019-03-28 Yale University ANTI-YKL40 ANTIBODIES AND METHODS OF USE
KR102083478B1 (ko) 2017-12-28 2020-04-28 한양대학교 산학협력단 Chi3l1 억제제를 유효성분으로 하는 암의 폐 전이 예방 또는 치료용 약학 조성물
WO2019217450A1 (en) * 2018-05-08 2019-11-14 Rhode Island Hospital Anti-chi3l1 antibodies for the detection and/or treatment of nonalcoholic fattly liver disease/nonalcoholic steatohepatitis and subsequent complications
WO2020097347A1 (en) * 2018-11-07 2020-05-14 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents for the treatment of fibrosis
TWI733274B (zh) 2018-12-13 2021-07-11 財團法人生物技術開發中心 抗人類csf-1r抗體及其用途
KR102142499B1 (ko) * 2019-09-11 2020-08-10 재단법인 오송첨단의료산업진흥재단 Ykl-40 표적 인간 단일클론항체
US11498978B2 (en) 2020-05-05 2022-11-15 Bio-Y A/S YKL-40 antibody
KR20230011064A (ko) * 2021-07-13 2023-01-20 충북대학교 산학협력단 Chi3L1에 특이적인 인간화 단일클론항체를 포함하는 대식세포의 M2 분극화 억제 및 암의 치료용 조성물
EP4702056A1 (en) * 2023-04-28 2026-03-04 Bio-Y A/S Antibodies against ykl-40 and uses thereof
US12428495B2 (en) * 2023-04-28 2025-09-30 Bio-Y A/S Antibodies against YKL-40 and uses thereof
WO2025048518A1 (ko) * 2023-08-31 2025-03-06 충북대학교 산학협력단 Ｃｈｉ３ｌ１에 특이적인 인간 단일클론항체를 포함하는 류마티스 관절염 예방 또는 치료용 조성물

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624972A (en) * 1947-05-12 1953-01-13 Leo R Burg Ice fishing rig
US3016648A (en) * 1958-06-25 1962-01-16 Robert D Ingersoll Mechanical fishing device
US3238658A (en) * 1965-06-28 1966-03-08 Eaumett A Hall Automatic fish catcher
US3474561A (en) * 1967-10-19 1969-10-28 Alfred R Mcconkey Ice fishing rig with self-contained automatic catcher
US3686785A (en) * 1971-02-26 1972-08-29 John L Dixon Fishing device
US4021958A (en) * 1975-10-06 1977-05-10 Snodie William R Ice fishing tip-up
US4083139A (en) * 1976-10-22 1978-04-11 Schwend Gerald M Ice fishing apparatus
US4085536A (en) * 1976-12-13 1978-04-25 Wood Jr Everett J Automatic fishing device
US4321767A (en) * 1979-07-06 1982-03-30 Hodshire Vincent B Ice fishing apparatus
US4373287A (en) * 1980-10-03 1983-02-15 Grahl Paul F Fishing tip-up
US4354324A (en) * 1980-12-08 1982-10-19 Eblen James H Fishing rod holding device
US4393615A (en) * 1981-11-30 1983-07-19 Hodshire Vincent B Fishing apparatus
US4416079A (en) * 1982-06-07 1983-11-22 Hodshire Vincent B Fishing apparatus
US4471553A (en) * 1982-06-30 1984-09-18 Copeland Darrell L Spring loaded fishing rod holder
US4461113A (en) * 1982-07-30 1984-07-24 G. Gene Henthorn Automatic fishhook setting apparatus
US4434573A (en) * 1982-09-16 1984-03-06 Hodshire Vincent B Fishing apparatus
CA1268040A (en) * 1986-07-04 1990-04-24 Warren Cooper Semi-automatic fishing apparatus
US4837965A (en) * 1988-04-14 1989-06-13 True Donovan B Ice fishing tip-up
US4941278A (en) * 1989-12-06 1990-07-17 Steve Verkuil Vertical fishing trip-up
US5050333A (en) * 1990-11-29 1991-09-24 Joe Debreczeni Fishing rig
US5274944A (en) * 1990-12-31 1994-01-04 Laessig Kenneth R Tip-up
US7229770B1 (en) 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5491923A (en) * 1994-01-31 1996-02-20 Zingrone; Thomas G. Fishing pole holder
CN1068309C (zh) * 1994-07-04 2001-07-11 旭化成工业株式会社 氨基脲衍生物及含其的涂料组合物
US5570534A (en) * 1995-06-06 1996-11-05 Michael R. Bowen Fishing rod jigger and automatic hook setting device
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
US5911569A (en) * 1998-02-06 1999-06-15 Isakson; Eric Ice fishing hole cover and indicator
US5992080A (en) * 1999-03-29 1999-11-30 Allen; Garth M. Fishing trap
US6772551B1 (en) * 1999-05-25 2004-08-10 Richard D. J. Bielinski, Sr. Hook set and rod holder
US20050214297A1 (en) * 2004-02-25 2005-09-29 Medimmune, Inc. Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
EP1856153B1 (en) * 2005-02-28 2010-12-29 Bio-Y A/S Ykl-40 monoclonal antibodies

Also Published As

Publication number Publication date
CA2599439A1 (en) 2006-08-31
AU2006218237A1 (en) 2006-08-31
US20120149882A1 (en) 2012-06-14
US8673301B2 (en) 2014-03-18
ES2358917T3 (es) 2011-05-16
EP1856153B1 (en) 2010-12-29
DE602006019205D1 (de) 2011-02-10
ATE493439T1 (de) 2011-01-15
EP1856153A1 (en) 2007-11-21
US8053563B2 (en) 2011-11-08
WO2006089549A1 (en) 2006-08-31
US20090175870A1 (en) 2009-07-09
AU2006218237B2 (en) 2012-01-12
JP2008531608A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
PL1856153T3 (pl) Przeciwciała monoklonalne YKL-40
BRPI0613382A8 (pt) anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor
NZ592432A (en) Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
AU2010220421A8 (en) Antibodies against a proliferating inducing ligand (APRIL)
TN2012000555A1 (en) Antibodies to human gdf8
GB201020995D0 (en) Biological materials and uses thereof
MA29595B1 (fr) Anticorps anti-cd40 humanises et procedes d'utilisation
TW200639182A (en) Antibody variants and uses thereof
NZ592973A (en) Compositions and methods of using angiopoietin-like 4 protein
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
SG10201407388XA (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
ATE459653T1 (de) Monoklonale anti-cd71-antikörper und deren verwendung zur behandlung maligner tumorzellen
AU2006226733A8 (en) Antibodies against CD38 for treatment of multiple myeloma
NZ609501A (en) Antibodies to notum pectinacetylesterase
TW200714711A (en) Anti-cd-20 monoclonal antibody
NZ592830A (en) Process for the modulation of the antagonistic activity of a monoclonal antibody
TN2009000194A1 (en) Novel antiproliferation antibodies
MX2010005966A (es) Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7).
MX2009008608A (es) Anticuerpos monoclonales anti-cxcl13.
MX2009010701A (es) Metodos para inhibir la union de endosialina a ligandos.
TN2012000466A1 (en) Humanized anti cxcr4 antibodies for the treatment of cancer
SG160248A1 (en) Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
MX347247B (es) Agentes capaces de la activación de células t regulatorias cd4+cd25+ y su uso en el tratamiento de enfermedad.
NZ602515A (en) Proteins that bind pi16 and uses thereof